TAVI May Improve Cognitive Function in Patients with Prior Deterioration

Cognitive Function TAVIThis work studies cognitive evolution after transcatheter aortic valve implantation (TAVI). Previous smaller studies reported conflicting results on cognitive function after TAVI.

 

This study prospectively included 229 patients who were ≥70 years old, had undergone TAVI and were assessed using the Mini Mental State Examination before and 6 months after the procedure. Cognitive deterioration or improvement was defined as a decrease or increase in the Mini Mental State Examination score of at least 3 points between baseline and 6 months.

 

Cognitive deterioration was found in 29 patients (12.7%), although no statistically significant predictor of this event was identified. However, observation of the 8 patients with the highest deterioration score (Mini Mental State Examination score decrease of ≥5 points) revealed possible specific causes, such as postinterventional delirium, postinterventional stroke, progressive renal failure, progressive heart failure, or preexisting cerebrovascular disease.

 

There were 48 patients with baseline cognitive deterioration (Mini Mental State Examination score <26 points), of whom 18 (37.5%) improved significantly.

 

The preinterventional aortic valve area was lower in patients who cognitively improved after the procedure (mean baseline aortic valve area 0.6 cm²) when compared with patients whose score remained similar to their baseline score (mean baseline aortic valve area 0.7 cm²; p = 0.01).

 

Conclusion

This is the first study providing evidence that transcatheter aortic valve replacement may result in cognitive improvement among patients who had preprocedural cognitive impairment, which may be possibly related to hemodynamic improvement. This study also confirms that some patients experience cognitive deterioration after the procedure.

 

Original title: Evolution of Cognitive Function After Transcatheter Aortic Valve Implantation.

Reference: Andreas W. Schoenenberger et al. Circ Cardiovasc Interv. 2016 Oct;9(10).

 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....